Study shows StrataNGS substantially increases patient access to tissue-based comprehensive genomic profiling.
Arboretum_JDAugust 23, 2021
Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced…
Arboretum_JDMay 19, 2021
Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced…
Arboretum_JDMarch 2, 2021
Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced…
Arboretum_JDJanuary 13, 2021
Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, recently announced…
Arboretum_JDOctober 28, 2020
Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced…
Arboretum_JDJuly 21, 2020
Award-Winning Author of The Art of Healthcare Innovation interviews Dan Rhodes, PhD, Co-founder and CEO…
Arboretum_JDMarch 27, 2020
Strata Oncology, Inc., Strata Oncology, a precision oncology company enabling molecular indications for cancer therapeutics,…
Arboretum_JDJuly 30, 2019
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, and…
Arboretum_JDMay 2, 2019
